On November 26, 2024 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, reported that company management will participate at multiple upcoming investor conferences (Press release, Xencor, NOV 26, 2024, View Source [SID1234648666]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Sandler 36th Annual Healthcare Conference
Date: Tuesday, December 3, 2024
Presentation Time: 2:00 p.m. ET / 11:00 a.m. PT
Location: New York City
7th Annual Evercore HealthCONx Conference
Date: Wednesday, December 4, 2024
Presentation Time: 3:50 p.m. ET / 12:50 p.m. PT
Location: Coral Gables, Florida
Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.